Glanbia appoints two independent non-executive directors
Mary Minnick was previously a partner of Lion Capital LLP, a consumer-focused private equity firm, from 2007 to 2018.
In that role, Ms Minnick was involved in a number of successful investments in well-known retail and consumer branded companies, several of which she chaired.
Prior to that, Ms. Minnick had a 23-year career with The Coca-Cola Company, where she held a variety of senior management positions, including Chief Operating Officer of the Asian region, Division President roles in the Japan, South Pacific and Asian regions, and ultimately as the company's Chief Marketing Officer and Global President of Strategy and Innovation.
Ms. Minnick is an experienced Board Director and is currently a member of the Boards of Target Corporation and Leo Holdings Corp, both of which are publicly-traded in the US.
Previously she was a member of the Boards of Heineken NV and Whitewave Foods, also US publicly traded.
Ms. Minnick holds an MBA from Duke University in the US and a BS in Business Administration from Bowling Green State University in the US.
Richard Laube was CEO of Nobel Biocare, a Swiss listed medical device business, from April 2011 to April 2016.
Prior to that Mr. Laube served as Executive Board Member of Nestlé SA, from April 2005 to September 2010, and served operationally as CEO of Nestlé Nutrition.
Before Nestlé, he served as Executive Committee member of Roche Holding AG and was operationally responsible for Roche Consumer Health.
Earlier in his career he held positions of increasing responsibility in brand and general management at Procter & Gamble, including international assignments in Switzerland, the USA, Japan, Germany and Brazil.
Mr. Laube is an experienced company director, having served as Chairman of Atkins Nutritionals Inc. from January 2011 to July 2017 and remained as independent director of the Simply Good Foods Company upon the company's successful initial public offering on NASDAQ in July 2017.
He currently serves as a Director of Gnubiotics Sciences and Piqur Therapeutics SA.
He has previously served as independent board member of Logitech SA. ■